The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

PeterS

Forum Replies Created

Viewing 3 reply threads
  • Replies
      PeterS
      Participant

        Hi,

        I hope you can get on a BRAF inhibitor trial or expanded access.  There is an issue with resistance and side-effects.  Ideally you would want to get a combined BRAFi+MEKi trial which seems to help overcoming some of the resistance, but has less of the nasty side effects that BRAFi might have.

        Still, BRAFi by itself seems on paper a good option as after resistance there may be a benefit in moving onto MEKi.  Ask your oncologist if you can get vemurafenib on expanded access.

        I myself (stage 4 diagnosed in March 11) was 'fortunate' (everything is relative) to be able to get onto the phase 3 MEK inhibitor trial from GSK.  There is no point in moving onto BRAFi.

        I guess the reason why your oncologist wants to wait for the results and get you onto targeted therapy is to reduce tumour growth (I had 50 to 75% reduction in 6 weeks) which would buy time.  Yervoy takes time to kick in and as with any of those drugs, it may not work, something you don't find out until one or two months later.

        Boots, keep going and don't give up.

        PeterS
        Participant

          Hi,

          I hope you can get on a BRAF inhibitor trial or expanded access.  There is an issue with resistance and side-effects.  Ideally you would want to get a combined BRAFi+MEKi trial which seems to help overcoming some of the resistance, but has less of the nasty side effects that BRAFi might have.

          Still, BRAFi by itself seems on paper a good option as after resistance there may be a benefit in moving onto MEKi.  Ask your oncologist if you can get vemurafenib on expanded access.

          I myself (stage 4 diagnosed in March 11) was 'fortunate' (everything is relative) to be able to get onto the phase 3 MEK inhibitor trial from GSK.  There is no point in moving onto BRAFi.

          I guess the reason why your oncologist wants to wait for the results and get you onto targeted therapy is to reduce tumour growth (I had 50 to 75% reduction in 6 weeks) which would buy time.  Yervoy takes time to kick in and as with any of those drugs, it may not work, something you don't find out until one or two months later.

          Boots, keep going and don't give up.

          PeterS
          Participant

            Hi,

            Cancer sucks indeed.  I hope you are responding to GSK1120212.  I am on the same trial with the usual side-effects like rash (fortunately relatively mild) and joint pain.

            All the best!

            Peter

            PeterS
            Participant

              Hi,

              Cancer sucks indeed.  I hope you are responding to GSK1120212.  I am on the same trial with the usual side-effects like rash (fortunately relatively mild) and joint pain.

              All the best!

              Peter

              PeterS
              Participant

                The problem is that there won't be many cases where this has been tried (just because of the study protocols, liability etc.) 

                For those in the EU, if you responded previously to a BRAF inhibitor (from Roche/GSK/…) and stopped responding a while ago, it may be worth asking your oncologist to get in touch with Roche to see if you can be enrolled in the Vemurafenib expanded access programme (BRIM4).

                It is only when patients try it that other cases can be found.  From a patient point of view, if you have no other treatment lined up, you have nothing to lose.  One knows pretty quicky if there is a response again or not (if you have skin lesions).

                Please reply to the thread if you managed to get on BRIM4 and respond again.

                Thank you,

                Peter (Stage 4, lung, skin and brain mets and just became Vemurafenib resistant)

                PeterS
                Participant

                  The problem is that there won't be many cases where this has been tried (just because of the study protocols, liability etc.) 

                  For those in the EU, if you responded previously to a BRAF inhibitor (from Roche/GSK/…) and stopped responding a while ago, it may be worth asking your oncologist to get in touch with Roche to see if you can be enrolled in the Vemurafenib expanded access programme (BRIM4).

                  It is only when patients try it that other cases can be found.  From a patient point of view, if you have no other treatment lined up, you have nothing to lose.  One knows pretty quicky if there is a response again or not (if you have skin lesions).

                  Please reply to the thread if you managed to get on BRIM4 and respond again.

                  Thank you,

                  Peter (Stage 4, lung, skin and brain mets and just became Vemurafenib resistant)

                  PeterS
                  Participant

                    The problem is that there won't be many cases where this has been tried (just because of the study protocols, liability etc.) 

                    For those in the EU, if you responded previously to a BRAF inhibitor (from Roche/GSK/…) and stopped responding a while ago, it may be worth asking your oncologist to get in touch with Roche to see if you can be enrolled in the Vemurafenib expanded access programme (BRIM4).

                    It is only when patients try it that other cases can be found.  From a patient point of view, if you have no other treatment lined up, you have nothing to lose.  One knows pretty quicky if there is a response again or not (if you have skin lesions).

                    Please reply to the thread if you managed to get on BRIM4 and respond again.

                    Thank you,

                    Peter (Stage 4, lung, skin and brain mets and just became Vemurafenib resistant)

                    PeterS
                    Participant

                      Hi Frank,

                      I have been thinking the same with regards to why waiting.  It is true that they work pretty quickly, IF there is response.  Here are a few factors to think about.  First of all, which inhibitor are you going to give (BRAF or MEK).  There are different side effects of taking each of these.  Given the probability of the tumor being BRAF positive (on average 0.5, but higher for young people) and response rates, the probability of responding is 0.2 to 0.3 (assuming no test was done).  Response is higher for BRAF inhibitors than MEK inhibitors.  They are not readily available yet, and when they are it will no doubt be cheap.  Just randomly placing somebody on a drug will possibly exclude them from certain trials.

                      Hopefully in the near future, these targeted drugs will become the new standard and side effects are well understood and managed.  Maybe by then, the test for BRAF status may be a lot quicker.  

                      I also hope that something similar can be found for folk testing BRAF negative to quickly help them reduce tumours.

                      Ipi is a hope for all of us to then keep things stable afterwards.

                      Peter, Stage IV

                      on GSK1120212 (after waiting a few weeks for the BRAF tests while tumours were aggressively growing)

                      PeterS
                      Participant

                        Hi Frank,

                        I have been thinking the same with regards to why waiting.  It is true that they work pretty quickly, IF there is response.  Here are a few factors to think about.  First of all, which inhibitor are you going to give (BRAF or MEK).  There are different side effects of taking each of these.  Given the probability of the tumor being BRAF positive (on average 0.5, but higher for young people) and response rates, the probability of responding is 0.2 to 0.3 (assuming no test was done).  Response is higher for BRAF inhibitors than MEK inhibitors.  They are not readily available yet, and when they are it will no doubt be cheap.  Just randomly placing somebody on a drug will possibly exclude them from certain trials.

                        Hopefully in the near future, these targeted drugs will become the new standard and side effects are well understood and managed.  Maybe by then, the test for BRAF status may be a lot quicker.  

                        I also hope that something similar can be found for folk testing BRAF negative to quickly help them reduce tumours.

                        Ipi is a hope for all of us to then keep things stable afterwards.

                        Peter, Stage IV

                        on GSK1120212 (after waiting a few weeks for the BRAF tests while tumours were aggressively growing)

                        PeterS
                        Participant

                          Lisa,

                          I hope you are coping OK with the DTIC treatment!  Lots of strength the coming months.

                          Did you test BRAF negative?

                          Peter, Stage 4

                          PeterS
                          Participant

                            Lisa,

                            I hope you are coping OK with the DTIC treatment!  Lots of strength the coming months.

                            Did you test BRAF negative?

                            Peter, Stage 4

                            PeterS
                            Participant

                              Hi,

                              I am fortunate that my rash is mild (nothing like Jonah's post on http://www.groinstrong.com 

                              The whole time of the course I am prescribed Doxycycline (2x100mg).  Recently I got Pyridoxine (vit B6) (3x50mg).

                              Every day I put on Diprobase all over the body  (sometimes twice a day for the parts with rash).  

                              The hydrocortisone 1% cream didn't have much effect on me.  Now trying Clindamycin although such a small stick for that much surface is time consuming.

                              About 3 weeks ago I had a rash on my scalp and got Elocon.  That stuff did wonders and cleared up the problem in a few days.  It dries out the skin, so I had to put Diprobase on the days I was treating it with Elocon.  Now that the problem is resolved, I now use Oilatum scalp shampoo and haven't had issues since.

                              After working in the garden, I had cracked skin on two fingers which had bled.  Even though it was healing, the protocol seems to stipulate that I had to be taken off the drug for a week.  It was also unfortunate that I had two mouth ulcers which I was successfully treating with Bonjela.  It was unfortunate but they have to stick to the rules.  I now cream up my hands with Neutrogena cream almost every time after I wash them, and twice a day I use Corsodyl mouth wash.  The bottom of my feet and heels tend to get dry so I treat it with Scholl Cracked Heel Repair Cream if it starts to get worse, or otherwise with the regular Diprobase.

                              Just to complete the list, I also use the Oilatum shower gel on my face especially as it is easier to make sure my ears are all greased up.

                              Peter

                              PeterS
                              Participant

                                Hi,

                                I am fortunate that my rash is mild (nothing like Jonah's post on http://www.groinstrong.com 

                                The whole time of the course I am prescribed Doxycycline (2x100mg).  Recently I got Pyridoxine (vit B6) (3x50mg).

                                Every day I put on Diprobase all over the body  (sometimes twice a day for the parts with rash).  

                                The hydrocortisone 1% cream didn't have much effect on me.  Now trying Clindamycin although such a small stick for that much surface is time consuming.

                                About 3 weeks ago I had a rash on my scalp and got Elocon.  That stuff did wonders and cleared up the problem in a few days.  It dries out the skin, so I had to put Diprobase on the days I was treating it with Elocon.  Now that the problem is resolved, I now use Oilatum scalp shampoo and haven't had issues since.

                                After working in the garden, I had cracked skin on two fingers which had bled.  Even though it was healing, the protocol seems to stipulate that I had to be taken off the drug for a week.  It was also unfortunate that I had two mouth ulcers which I was successfully treating with Bonjela.  It was unfortunate but they have to stick to the rules.  I now cream up my hands with Neutrogena cream almost every time after I wash them, and twice a day I use Corsodyl mouth wash.  The bottom of my feet and heels tend to get dry so I treat it with Scholl Cracked Heel Repair Cream if it starts to get worse, or otherwise with the regular Diprobase.

                                Just to complete the list, I also use the Oilatum shower gel on my face especially as it is easier to make sure my ears are all greased up.

                                Peter

                            Viewing 3 reply threads